Goebel, C
Healthcare provider evaluation
The boxed warning also mentions the risk of pancreatitis and that the medication is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) and patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
June 2025 On June 6, 2025, the European Medicines Agencys (EMA) safety committee concluded that Novo Nordisks semaglutide-containing drugsincluding the popular weight-loss drug Wegovy and diabetes treatments Ozempic and Rybelsusmay cause rare but serious cases of non-arteritic anterior ischemic optic neuropathy (NAION), a sudden and painless vision loss in one eye due to optic nerve damage
Rogovski P, Cadamuro RD, da Silva R, de Souza EB, Bonatto C, Viancelli A, et al
IGF-1 LR3 (Long R3 Insulin-Like Growth Factor 1) is a synthetic, lengthened analogue of human IGF-1 , designed to exhibit greater metabolic stability and reduced binding to IGF-binding proteins (IGFBPs)